• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

ASML's Q3 orders were a positive surprise, as were comments on next year's growth

CANATUAnalyst Comment15.10.2025 klo 10.40
Atte RiikolaAnalyst
Discuss

Summary

  • ASML's Q3 orders exceeded expectations, with orders totaling 5.4 BNEUR, surpassing the anticipated 4.9 BNEUR, driven by strong demand for EUV equipment.
  • The company reported Q3 revenue of 7.5 BNEUR, slightly below the consensus estimate, but EBIT aligned with forecasts at 2.47 BNEUR.
  • ASML projects a 15% revenue growth for the full year, with a strong Q4 expected, and anticipates further growth in 2026, driven by AI investments despite a forecasted decline in China's revenue.
  • Canatu sees growth potential in supplying carbon nanotube pellicles for ASML's advanced EUV systems, which outperform traditional materials under high thermal and mechanical stress.

This content is generated by AI. You can give feedback on it in the Inderes forum.

Translation: Original published in Finnish on 10/15/2025 at 09:58 am EEST

ASML, which has a virtual monopoly on EUV lithography machines, reported its Q3 results on Wednesday, which exceeded analyst expectations in terms of orders. The outlook comments anticipating growth for 2026 are also a positive signal, as the company's comments regarding 2026 have previously been more uncertain. The growth in AI investments is creating a growing demand for ASML's most advanced equipment, even though demand for older generation technology in China is expected to decrease next year. From Canatu's point of view, the growth in demand for the most advanced devices is key, as they will require the company's pellicles made from carbon nanotubes.

Q3 earnings in line with expectations, orders received slightly better

ASML’s Q3 revenue (7.5 BNEUR) remained approximately stable year-on-year and was slightly below analysts' consensus estimate (7.7 BNEUR). Q3 EBIT was 2.47 BNEUR and was in practice in line with the consensus forecast. However, the orders received in the quarter (5.4 BNEUR) were better than expected (4.9 BNEUR). Of the orders, 3.6 billion are for EUV equipment.

The company expects revenue to grow in 2026

In its outlook, ASML expects Q4 revenue to be 9.2–9.8 BNEUR and the full year revenue to grow by approximately 15%. The company expects the gross margin to be around 52% for the whole year. The company thus expects Q4 to be a strong quarter in terms of revenue.

The company's comments concerning 2026 expect revenue growth compared to this year, with more information to be provided in January. According to the company, AI investments continue to be a key demand driver, and as a result, demand for the company's latest EUV equipment is growing. At the same time, however, the company expects China's revenue to decrease in 2026, as business in this region has been exceptionally strong in 2024-2025. Due to the geopolitical situation, ASML is not supplying the most advanced EUV equipment to China, but rather older technology.  

New system deliveries from ASML create a growth market for Canatu in the coming years

ASML's latest EUV systems, with power exceeding 500 watts, are particularly interesting from Canatu's perspective. The use of these devices requires EUV pellicle membranes that protect the photomask in the production process, which can be made from Canatu's CNT. The characteristics of CNTs produced using Canatu’s patented method seem to be better suited for this purpose than competitors' products, which gives the company an attractive starting point to pursue a significant position in this market. In systems above 500 watts, the properties of Canatu's carbon nanotube pellicle membranes are clearly superior to traditional composite membranes, which can no longer properly withstand higher thermal loads and mechanical stress.

Login required

This content is only available for logged in users

Create account

Canatu is a technology company active in deep technology that creates carbon nanotubes (Canatu CNT), related products and manufacturing equipment for the semiconductor, automotive and medical diagnostics industries. The company operates through two business models, firstly using their own reactors to develop and manufacture CNT products. Second, the company sells its CNT reactors and licenses its related technology, allowing customers to produce the products themselves under a limited license.

Read more on company page

Key Estimate Figures31.08.2025

202425e26e
Revenue22.014.929.8
growth-%62.1 %-32.4 %100.1 %
EBIT (adj.)-4.8-11.6-7.6
EBIT-% (adj.)-21.9 %-78.2 %-25.5 %
EPS (adj.)-0.01-0.24-0.15
Dividend0.000.000.00
Dividend %
P/E (adj.)neg.neg.neg.
EV/EBITDAneg.neg.neg.

Forum discussions

I’ll add this brilliant Veritasium documentary about ASML’s equipment to this thread as well. It’s also in other threads if you’ve happened ...
6/28/2026, 6:45 AM
by Karibu
6
Tärkeimmät talousuutiset | Kauppalehti – 24 Jun 26 Tämä härveli maksaa yli 350 miljoonaa euroa, ja kaikki viedään käsistä Euroopan suurin pö...
6/28/2026, 5:54 AM
by HANS
6
Changes to Canatu’s leadership team structure following the appointment of the new CEO. Inderes Canatu muuttaa johtoryhmärakennettaan toiminnan...
6/25/2026, 12:38 PM
by Atte Riikola
16
Eka already provided a good answer to the question, and indeed, rough assumptions have been made based on available data points, not any carved...
6/24/2026, 5:49 AM
by Atte Riikola
6
I suspected there might be some kind of calculation exercise going on here, but I consider the numbers quite low if triple-digit quantities ...
6/23/2026, 8:17 PM
by Pandakarhu
4
Resident know-it-all here, hi! Canatu’s management likely hasn’t disclosed the production volumes of pellicles per reactor, but one can try ...
6/23/2026, 8:12 PM
by Pohjolan Eka
14
Summer is always a good time to go through Inderes’ comprehensive initiation reports. I have read Atte’s well-written initiation report a couple...
6/23/2026, 6:54 PM
by Pandakarhu
4